Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks Overview

Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks Overview

Pharmaceuticals 01/10/2015 145 List Figures TOC

Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks Overview(2)
Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks delves into the rapidly evolving field of digital pathology, briefly reviewing the underlying scientific and technological concepts and providing an insightful perspective on various factors thought to be of significance to the development and future of this space.



The opening chapters will provide an overview of digital pathology including: terminology and definitions for the purposes of this report, types of digital imaging systems (including whole slide scanners), and their technical underpinnings as well as current and emerging applications. A brief overview of the digital pathology market will cover identified drivers and obstacles as well as current forecasts. The U.S. Food and Drug Administration and several standards organizations will be profiled with regard to activities that may impact the furtherance of this field. Included in this section is an interview with Craig Revie, Chair of the International Color Consortium’s Medical Imaging Working Group and project coordinator for the development of a calibration system for digital microscopes.



Participating companies, including 3DHISTECH, Applied Spectral Imaging, Carl Zeiss Microscopy GmbH, DigiPath Corp., FFEI Ltd., Huron Technologies, Nikon Instruments, PerkinElmer, and Philips Digital Pathology Solutions, have provided valuable insight as to the evolution of digital pathology within their businesses, the details of their current imaging systems, strategies, and techniques, as well as their individual perspectives on the establishment of standards in digital pathology, the challenges the field may face, and the benefits that await as a digital environment becomes commonplace in pathology. Interviews with the experts from the participating companies are also featured.



The report concludes with a unique look at the current climate of the digital pathology space based on a survey conducted by Insight Pharma Reports which polled a group of individuals identified as end users or developers of digital pathology technologies. Review of these results compares the perspectives of both demographics on several important topics revealing areas of commonality and also divergence. Topics include aspects of the technology that are in most need of improvement, and the challenges and benefits associated with the use and development of digital pathology technologies.